Steroid inhalers for cough
Pro Research Analysisby 
Searched over 200M research papers
Inhaled Steroid Therapy for Cough: Effectiveness and Patient Outcomes
Inhaled Steroids for Persistent and Acute Cough
Inhaled corticosteroids (ICS) have been shown to reduce cough symptoms in a variety of conditions, including persistent cough, cough variant asthma, acute bronchitis, and post-infectious cough. Studies in adults with cough lasting two weeks or more found that inhaled fluticasone propionate significantly reduced cough scores compared to placebo, especially in nonsmokers, suggesting a clear benefit for otherwise healthy adults who do not smoke . Similarly, in patients with acute viral bronchitis, inhaled corticosteroids (often combined with long-acting beta-agonists) led to cough resolution in about nine days on average, with most patients reporting significant improvement in quality of life .
Cough Variant Asthma and Inhaled Steroids
Cough variant asthma (CVA) is a common cause of chronic cough. Multiple studies have demonstrated that inhaled steroids are effective for both short-term symptom relief and long-term control in CVA. Patients treated with inhaled corticosteroids after an initial course of oral steroids experienced sustained relief from debilitating cough, with most remaining symptom-free over long-term follow-up . Both atopic and non-atopic patients with CVA responded well to steroid therapy, though atopic patients sometimes required a longer duration for optimal improvement . Inhaled budesonide-formoterol inhalers also led to significant improvement in cough symptoms in the majority of patients with CVA .
Inhaled Steroids for Post-Infectious and Post-COVID Cough
Inhaled steroids have also been found effective in treating persistent cough following respiratory infections, including COVID-19. Patients with post-COVID persistent cough who received inhaled budesonide recovered faster, weaned off oxygen support earlier, and were discharged from the hospital sooner compared to those receiving standard care alone . In children with whooping cough, adding inhaled budesonide to standard therapy reduced the number and duration of coughing attacks and shortened hospital stays .
Delivery Methods and Device Considerations
The method of delivering inhaled steroids can influence their effectiveness and patient experience. Nebulized corticosteroids may provide superior symptom control compared to dry powder inhalers or metered-dose inhalers in some patients with cough variant or cough-predominant asthma, likely due to differences in particle distribution within the airways . Additionally, dry powder inhalers like the Turbuhaler have been associated with fewer coughs immediately after inhalation and higher patient preference compared to pressurized metered-dose inhalers .
Safety and Side Effects
Short-term use of inhaled steroids for cough appears to be safe, with no significant negative effects on voice parameters observed after one month of treatment with inhaled budesonide in patients with subacute or chronic cough .
Conclusion
Inhaled steroid inhalers are effective in reducing cough symptoms across a range of conditions, including persistent cough, cough variant asthma, acute bronchitis, post-infectious cough, and post-COVID cough. They offer both short-term relief and long-term control, with benefits seen in both adults and children. The choice of inhaler device and delivery method can impact both efficacy and patient satisfaction. Overall, inhaled steroids represent a valuable option for managing cough when underlying causes are appropriately addressed.
Sources and full results
Most relevant research papers on this topic